| Class 2 Device Recall ETEST ETP32 (Ertapenem) | |
Date Initiated by Firm | April 25, 2017 |
Date Posted | May 03, 2017 |
Recall Status1 |
Terminated 3 on February 24, 2022 |
Recall Number | Z-2095-2017 |
Recall Event ID |
76983 |
510(K)Number | K020748 |
Product Classification |
Manual antimicrobial susceptibility test systems - Product Code JWY
|
Product | ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging
ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria
(Only 531640 was distributed in the United States) |
Code Information |
REF 531640 Lot Number - 1003149850, 1003157690, 1003585350, 1003732380, 1003910410, 1004142070, 1004113370, 1004325260, 1004382730, 1004482780, 1004785720, 1004890160, 1005134380, 1005134390, 1005357180, 1005442470 --- REF 531600 - was not distributed in the United States |
Recalling Firm/ Manufacturer |
BioMerieux SA Chemin De L'Orme Marcy L'Etoile France
|
Manufacturer Reason for Recall | False susceptible results |
FDA Determined Cause 2 | Under Investigation by firm |
Action | bioMerieux sent an Urgent Product Safety Correction Notice on April 25, 2017 to U. S. consignees. The letter requested that they provide the notice to all appropriate personnel in the laboratory, asking them to identify any possible False Susceptible results. The letter included a Acknowledgment Form to be returned. On this notice the consignee will indicate the number of kits discarded. For customers with questions please contact their local bioMerieux Customer Service representative. |
Quantity in Commerce | 3,238 units |
Distribution | NATIONWIDE DISTRIBUTION TO AL, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, IL, IN, IA, KS, KY, LA, M, MA, MD, MI, MN, MS, MO, MT, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, and WY |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = JWY
|
|
|
|